Estimate Recalculated Sep 9, 2024 12:31AM EST
Andrew R Robbins has an estimated net worth of $9.9 Million. This is based on reported shares across multiple companies, which include Cogent Biosciences, Inc., Harpoon Therapeutics, Inc., TURMERIC ACQUISITION CORP., and ARRAY BIOPHARMA INC.
Andrew R Robbins's CIK is 0001590157
2017 was Andrew R Robbins's most active year for acquiring shares with 8 total transactions. Andrew R Robbins's most active month to acquire stocks was the month of November. 2019 was Andrew R Robbins's most active year for disposing of shares, totalling 14 transactions. Andrew R Robbins's most active month to dispose stocks was the month of November. 2022 saw Andrew R Robbins paying a total of $3,410,808.00 for 700,167 shares, this is the most they've acquired in one year. In 2019 Andrew R Robbins cashed out on 2,044,527 shares for a total of $8,420,602.65, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!